Found 6 hits Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Phospholipase A2, membrane associated
(124/124 = 100%)†
(Homo sapiens (Human)) | BDBM23771
((3-{[1-benzyl-3-(carbamoylmethyl)-2-ethyl-1H-indol...)Show SMILES CCc1c(CC(N)=O)c2cc(OCCCP(O)(O)=O)ccc2n1Cc1ccccc1 Show InChI InChI=1S/C22H27N2O5P/c1-2-20-19(14-22(23)25)18-13-17(29-11-6-12-30(26,27)28)9-10-21(18)24(20)15-16-7-4-3-5-8-16/h3-5,7-10,13H,2,6,11-12,14-15H2,1H3,(H2,23,25)(H2,26,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of human non-pancreatic secretory phospholipase A2 (PLA2) in a chromogenic assay |
J Med Chem 39: 5137-58 (1997)
Article DOI: 10.1021/jm960486n
BindingDB Entry DOI: 10.7270/Q2639NV0 |
More data for this
Ligand-Target Pair | 
3D Structure (crystal) |
Phospholipase A2, membrane associated
(124/124 = 100%)†
(Homo sapiens (Human)) | BDBM23771
((3-{[1-benzyl-3-(carbamoylmethyl)-2-ethyl-1H-indol...)Show SMILES CCc1c(CC(N)=O)c2cc(OCCCP(O)(O)=O)ccc2n1Cc1ccccc1 Show InChI InChI=1S/C22H27N2O5P/c1-2-20-19(14-22(23)25)18-13-17(29-11-6-12-30(26,27)28)9-10-21(18)24(20)15-16-7-4-3-5-8-16/h3-5,7-10,13H,2,6,11-12,14-15H2,1H3,(H2,23,25)(H2,26,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| n/a | n/a | 470 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Universite Paris 7-Denis Diderot
| Assay Description
PLA2 activity is by using the fluorescent phospholipid analogue, beta-pyC-10-PG as the substrate. The increase in fluorescence (ex @342 nm and em@388... |
Bioorg Med Chem 16: 1242-53 (2008)
Article DOI: 10.1016/j.bmc.2007.10.077
BindingDB Entry DOI: 10.7270/Q2J964PK |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Phospholipase A2, membrane associated
(124/124 = 100%)†
(Homo sapiens (Human)) | BDBM23771
((3-{[1-benzyl-3-(carbamoylmethyl)-2-ethyl-1H-indol...)Show SMILES CCc1c(CC(N)=O)c2cc(OCCCP(O)(O)=O)ccc2n1Cc1ccccc1 Show InChI InChI=1S/C22H27N2O5P/c1-2-20-19(14-22(23)25)18-13-17(29-11-6-12-30(26,27)28)9-10-21(18)24(20)15-16-7-4-3-5-8-16/h3-5,7-10,13H,2,6,11-12,14-15H2,1H3,(H2,23,25)(H2,26,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| n/a | n/a | 470 | n/a | n/a | n/a | n/a | n/a | n/a |
Universit£ Paris Diderot
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant group 2A phospholipase A2 by fluorimetric assay |
Bioorg Med Chem 18: 3588-600 (2010)
Article DOI: 10.1016/j.bmc.2010.03.049
BindingDB Entry DOI: 10.7270/Q2ZG6SD9 |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Phospholipase A2, membrane associated
(124/124 = 100%)†
(Homo sapiens (Human)) | BDBM23771
((3-{[1-benzyl-3-(carbamoylmethyl)-2-ethyl-1H-indol...)Show SMILES CCc1c(CC(N)=O)c2cc(OCCCP(O)(O)=O)ccc2n1Cc1ccccc1 Show InChI InChI=1S/C22H27N2O5P/c1-2-20-19(14-22(23)25)18-13-17(29-11-6-12-30(26,27)28)9-10-21(18)24(20)15-16-7-4-3-5-8-16/h3-5,7-10,13H,2,6,11-12,14-15H2,1H3,(H2,23,25)(H2,26,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| n/a | n/a | 470 | n/a | n/a | n/a | n/a | n/a | n/a |
Université Paris7-Denis Diderot
Curated by ChEMBL
| Assay Description
Inhibition of human group IIA PLA2 by fluorimetric assay |
J Med Chem 50: 1618-26 (2007)
Article DOI: 10.1021/jm060082n
BindingDB Entry DOI: 10.7270/Q2TQ6174 |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Phospholipase A2, membrane associated
(124/124 = 100%)†
(Homo sapiens (Human)) | BDBM23771
((3-{[1-benzyl-3-(carbamoylmethyl)-2-ethyl-1H-indol...)Show SMILES CCc1c(CC(N)=O)c2cc(OCCCP(O)(O)=O)ccc2n1Cc1ccccc1 Show InChI InChI=1S/C22H27N2O5P/c1-2-20-19(14-22(23)25)18-13-17(29-11-6-12-30(26,27)28)9-10-21(18)24(20)15-16-7-4-3-5-8-16/h3-5,7-10,13H,2,6,11-12,14-15H2,1H3,(H2,23,25)(H2,26,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| n/a | n/a | 3.55E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibitory activity against porcine pancreatic Phospholipase A2 |
J Med Chem 39: 5137-58 (1997)
Article DOI: 10.1021/jm960486n
BindingDB Entry DOI: 10.7270/Q2639NV0 |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Phospholipase A2, membrane associated
(124/124 = 100%)†
(Homo sapiens (Human)) | BDBM23771
((3-{[1-benzyl-3-(carbamoylmethyl)-2-ethyl-1H-indol...)Show SMILES CCc1c(CC(N)=O)c2cc(OCCCP(O)(O)=O)ccc2n1Cc1ccccc1 Show InChI InChI=1S/C22H27N2O5P/c1-2-20-19(14-22(23)25)18-13-17(29-11-6-12-30(26,27)28)9-10-21(18)24(20)15-16-7-4-3-5-8-16/h3-5,7-10,13H,2,6,11-12,14-15H2,1H3,(H2,23,25)(H2,26,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| n/a | n/a | 9.11E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibitory activity against human pancreatic Phospholipase A2 |
J Med Chem 39: 5137-58 (1997)
Article DOI: 10.1021/jm960486n
BindingDB Entry DOI: 10.7270/Q2639NV0 |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Search and Browse
